Form 4 Tracker
Chemomab Therapeutics Ltd.
CMMB

2 insider filings · Latest: Aug 27, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Aug 28, 2026Sep 1 2:05 PMNeil Harris CohenDirector
Sale
1,000$2.80$2.8K33,000(D)

View →

Aug 27, 2026Sep 1 2:05 PMNeil Harris CohenDirector
Sale
1,304$2.85$3.7K34,000(D)

View →

May 29, 2026Jun 1 11:33 AMMor George AdiDirector, Chief Executive Officer
Purchase
9,804$2.07$20.2K139,131(D)

View →

Sep 12, 2024Sep 12 8:56 PMOrbiMed Israel Partners Limited Partnership
Proposed Sale
500,000$2.03$1.0M—

View →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Mar 16, 2026Sep 1 2:05 PMNeil Harris CohenDirector
Grant/Award
5,172$2.1418,075(D)

View →

Mar 16, 2025Sep 1 2:05 PMNeil Harris CohenDirector
Grant/Award
3,821$6.1612,903(D)

View →

Mar 18, 2024Sep 1 2:05 PMNeil Harris CohenDirector
Grant/Award
2,520$2.969,082(D)

View →

Mar 21, 2023Sep 1 2:05 PMNeil Harris CohenDirector
Grant/Award
1,714$6.486,562(D)

View →

Mar 7, 2022Sep 1 2:05 PMNeil Harris CohenDirector
Grant/Award
1,705$14.124,848(D)

View →

Apr 19, 2021Sep 1 2:05 PMNeil Harris CohenDirector
Grant/Award
2,971$109.043,143(D)

View →

Jul 16, 2020Sep 1 2:05 PMNeil Harris CohenDirector
Grant/Award
172$52.80172(D)

View →